1445A SOUTH 50TH STREET, RICHMOND, CA
Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
Reports Third Quarter 2025 Financial Results and Provides Business Updates
Reports Second Quarter 2025 Financial Results and Provides Business Updates
Submission of Matters to a Vote of Security Holders
Other Events
Reports First Quarter 2025 Financial Results and Provides Business Updates
Annual Report to Security Holders
Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
Q3
Q2
Q1
FY 2024
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
S-1MEF